Chronic Spontaneous Urticaria Triggered by the AstraZeneca/Oxford COVID-19 Vaccine with Achieved Remission: A Case Report
Stephanie G. Brooks, Anna M De Jong, Mina Abbaslou, Gordon Sussman
Abstract
New adverse reactions to the COVID-19 vaccines are being identified as vaccination rates increase worldwide. Recently, there have been two reports of Moderna (mRNA-1273) vaccine induced relapse of chronic spontaneous urticaria (CSU) that was previously well controlled. Herein, we report a case of AstraZeneca/Oxford (ChAdOx1) vaccine triggered CSU in a patient with no history of CSU with achieved remission.
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)VaccinationAdverse effectChronic urticariaSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakDermatologyVirologyImmunologyInternal medicineDiseaseOutbreakInfectious disease (medical specialty)Urticaria and Related ConditionsDrug-Induced Adverse ReactionsHeparin-Induced Thrombocytopenia and Thrombosis